The Monday Clinical Brief is a weekly literature-digest service founded by Dr Tim Hamilton, a Consultant in Palliative Medicine working in NHS Wales. It is a genuinely small, narrowly scoped product, and that narrowness is exactly what makes it worth looking at closely as an example of what clinician-led AI can do well.
The problem it addresses
Thousands of medical papers are published every week, spread across far more journals than any individual clinician could reasonably monitor alongside a full clinical workload. Important new evidence frequently does not reach everyday practice until a guideline update, a conference presentation, or a colleague happens to mention it, a genuinely inefficient and unpredictable way for practice-relevant findings to travel.
How the service actually works
The Monday Clinical Brief covers 31 medical specialties, from acute medicine and cardiology through to respiratory medicine and urology. For each specialty, it monitors the top five journals in that field, automatically querying PubMed each week for newly published articles from those journals. The resulting digest is delivered by email every Monday, opening with a short "This Week at a Glance" section that highlights the two or three most significant findings from that week's papers, giving a reader the headlines in roughly thirty seconds before deciding whether to read further.
The structure of each individual summary
Every article summary follows a consistent structure: the study type is stated explicitly, the underlying clinical question is set out plainly, the principal findings are presented with the actual numerical results rather than a vague paraphrase, potential clinical relevance is addressed directly, important limitations are stated alongside the positive findings rather than omitted, and direct PubMed and DOI links are provided for every article.
The design decisions worth crediting directly
Several choices behind this product deserve genuine credit rather than faint praise. No app or complicated workflow is required; it is a single scheduled email. Information is pushed to the clinician rather than requiring them to remember to search for it, which matters given how easily good intentions to "keep up with the literature" get crowded out by clinical workload. The summaries retain direct links back to the underlying publications rather than presenting themselves as a self-contained substitute for reading them. The service states this explicitly and unambiguously: summaries are described as a starting point for identifying relevant papers, not a substitute for reading the original research. And no patient data is processed anywhere in the service, since it operates entirely on publicly available PubMed abstracts.
How accessible the service actually is
The Monday Clinical Brief offers a four-week free trial, after which it costs £20 per year for one specialty, with additional specialties available for a modest £5 per year each. Subscribing with an NHS or institutional email address allows the journal links within each digest to open as full text through existing institutional access, rather than running into a paywall.
A focused product, not an attempt to replace the clinician
What stands out about this specific design is what it deliberately does not attempt to do. It does not diagnose, does not recommend management, and does not claim to synthesise an authoritative answer to a clinical question. It solves one clearly bounded problem, discovering what has recently been published in a clinician's own specialty, and does that one thing with a level of care, transparency and restraint that a more ambitious, less focused product might struggle to match.
Where iatroX fits as a complementary platform
iatroX, also founded by a practising UK clinician, solves a genuinely different problem. The Monday Clinical Brief helps a clinician discover what has recently been published. iatroX helps that same clinician answer the specific clinical question that arises once they have that new information, or at any other point in their working day, grounded in UK guidance and relevant evidence. One is proactive literature surveillance; the other is point-of-care clinical knowledge retrieval. They are not competing for the same moment in a clinician's workflow.
A credible model for UK clinician-led AI
Together, these two products illustrate a genuinely credible pattern for UK clinical AI: narrowly defined use cases rather than sprawling, all-purpose ambition; transparent access to underlying sources rather than opaque synthesis; honest acknowledgement of limitations rather than overclaiming; and products built around the specific, real workflows of NHS clinicians rather than adapted from a system built for a different healthcare context entirely.